MedTrace Logo

Study Evaluating the Effect of Isonatremic Dialysis Treatment in Chronic Kidney Disease Patients on Dialysis

NCT04809493 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-04-14

No results posted yet for this study

Summary

Aim of this study is to evaluate, in a population of chronic kidney disease patients on dialysis (Stage 5D), the effect of treatment with isonatremic dialysis (vs conventional dialysis), during an observational period of 2 months each, on:

* control of interdialytic weight gain
* perdialytic tolerance in terms of adverse events occurring during all of the sessions of the study
* body composition and thirst measured monthly during the 4 months of follow-up.
* tolerance to treatment.

Conditions

  • Chronic Kidney Diseases

Interventions

PROCEDURE

Conventional dialysis treatment

Conventional dialysis treatment

PROCEDURE

Isonatremic dialysis treatment

Isonatremic dialysis treatment

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Jean-Paul CRISTOL, Prof · UH MONTPELLIER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-12-01
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04809493 on ClinicalTrials.gov